TwinKnowledge | $3,700,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Certified by Founder
Lodge
Tenvie Therapeutics
start up
United States
- South San Francisco, California
- 09/01/2025
- Unknown
- $200,000,000
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
- Industry Biotechnology Research
- Website https://tenvie.com/
- LinkedIn https://www.linkedin.com/company/tenvie-therapeutics/
Cambrian Network | $5,900,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)